Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses

Leukemia. 2016 Oct;30(10):2116-2119. doi: 10.1038/leu.2016.152. Epub 2016 May 25.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Core Binding Factor Alpha 2 Subunit / metabolism
  • Disease Progression
  • ETS Translocation Variant 6 Protein
  • Gene Expression Regulation, Leukemic*
  • Humans
  • Immune System
  • Inflammation
  • Ligands
  • Mice
  • Mice, Transgenic
  • Neutralization Tests
  • PAX5 Transcription Factor / metabolism
  • Phenotype
  • Pre-B-Cell Leukemia Transcription Factor 1 / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
  • Precursor Cells, B-Lymphoid / immunology
  • Precursor Cells, B-Lymphoid / metabolism*
  • Proto-Oncogene Proteins c-ets / metabolism
  • Repressor Proteins / metabolism
  • Toll-Like Receptors / metabolism*

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • Core Binding Factor Alpha 2 Subunit
  • Ligands
  • PAX5 Transcription Factor
  • Pax5 protein, mouse
  • Pbx1 protein, mouse
  • Pre-B-Cell Leukemia Transcription Factor 1
  • Proto-Oncogene Proteins c-ets
  • Repressor Proteins
  • Runx1 protein, mouse
  • Tcf3 protein, mouse
  • Toll-Like Receptors